Humana Inc. (HUM)
Here's Why Investors Should Stay Neutral on Humana Stock for Now
HUM's Medicare growth, CenterWell expansion and strong cash flow support gains, but rising costs and high leverage keep caution in focus.
Humana Just Ripped 48% in a Month. Is It Outperforming Other Healthcare Stocks Like UnitedHealth and Cigna?
Shares of Humana (NYSE:HUM | HUM Price Prediction) are trading near $303 at midday Monday, slightly lower on the session after a flat open.
Humana: Perhaps The 'Buy The Dip' Thesis Was Right All Along (Rating Upgrade)
Humana Inc. is upgraded to Buy as shares rebound from a >65% decline, supported by improved CMS rate decisions and activist investor involvement. Despite 2026 EPS guidance below Q1 levels, HUM targets a sustainable 3%+ Medicare Advantage margin and long-term earnings growth by 2028. Recent Q1 results exceeded revenue and adjusted EPS expectations, with a favorable medical benefit ratio and affirmed 25% MA membership growth for 2026.
Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case
Humana (NYSE:HUM | HUM Price Prediction) stock received a price target raise to $254 from $182 from Piper Sandler, which maintained a Neutral rating.
Humana Beats Q1 Earnings Estimates on Increasing Premiums
HUM posts Q1 earnings beat as premiums surge and membership grows, but rising costs and benefit ratio pressure weigh on profit.
Humana Inc. (HUM) Q1 2026 Earnings Call Transcript
Humana Inc. (HUM) Q1 2026 Earnings Call Transcript
Humana (HUM) Beats Q1 Earnings and Revenue Estimates
Humana (HUM) came out with quarterly earnings of $10.31 per share, beating the Zacks Consensus Estimate of $9.97 per share. This compares to earnings of $11.58 per share a year ago.
Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly
Humana reported first quarter net income of nearly $1.2 billion as costs of care for older adults in its Medicare Advantage plans eased a bit but remained high.
Humana Profit Falls as Lower Medicare Ratings Hurt Bonuses
Humana reported lower first-quarter profit as the company faces earnings headwinds from lower Medicare Advantage Star Ratings for 2026.
Humana beats quarterly profit estimates on lower medical costs
Humana on Wednesday beat Wall Street estimates for first-quarter profit as the health insurer spent less on medical services than expected.
Mark Cuban's Cost Plus Drugs, Humana In Deal To Take On Employer Drug Costs
Mark Cuban's Cost Plus Drug Company and Humana's CenterWell Pharmacy Monday confirmed they have formed a partnership “to develop new end-to-end employer prescription solutions.”
Will Increasing Operating Costs Affect Humana's Q1 Earnings?
HUM heads into Q1 earnings with strong revenue growth expectations, but rising operating costs and a higher benefits ratio may weigh on profits.
